A 58-year-old man with dilated cardiomyopathy and NYHA Class III heart failure is started on a beta-blocker. Which clinical feature best distinguishes the cardioprotective effect of beta-blockers from that of ACE inhibitors in this patient?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.